发明名称 Method of treating neuronal injury by administering magnesium chloride and PEG
摘要 The invention provides methods and kits for treatment of pain or inflammation. In one embodiment, the kit comprises a biomembrane sealing agent, such as PEG, and a bioactive agent, such as a magnesium compound. The biomembrane sealing agent and/or the bioactive agent an intravenous administration, an intramuscular administration, an intrathecal administration, a subcutaneous administration, an epidural administration, a parenteral administration, an intra-articular administration, a direct application onto or adjacent to a site of the pathological condition, and any combinations thereof. Alternatively, the biomembrane sealing agent and/or the bioactive agent may be delivered from a pump or an implant.
申请公布号 US8840933(B2) 申请公布日期 2014.09.23
申请号 US200611418153 申请日期 2006.05.03
申请人 Warsaw Orthopedic, Inc. 发明人 Roy Josee;McKay William F.;Marx Jeffrey C
分类号 A61K33/14;A61K31/765;A61K9/08;A61K9/00;A61K31/717;A61K31/787;A61K33/06 主分类号 A61K33/14
代理机构 Sorell, Lenna & Schmidt, LLP. 代理人 Schmidt William D.;Sorell, Lenna & Schmidt, LLP.
主权项 1. A method of reducing the volume of lesion due to a spinal cord injury or a traumatic brain injury in a subject in need thereof, the method comprising: a) delivering to the subject a first injectable composition comprising magnesium chloride and 20-30% weight/volume of polyethylene glycol (PEG) in saline, wherein said magnesium chloride and PEG act synergistically to treat the injury; b) providing the dose of Mg in said magnesium chloride to be within a range from 0.115 to 0.230 mmol of Mg/kg of the subject's weight and providing the dose for PEG to be within a range from 0.7 to 1.4 g of PEG/kg of the subject's weight for the first injectable composition; c) delivering to the subject a second injectable composition comprising magnesium chloride and 20-30% weight/volume of PEG in saline within 24 hours of delivering the first injectable composition wherein said magnesium chloride and PEG act synergistically to treat the injury; d) providing the dose of Mg in said magnesium chloride to be within a range from 0.115 to 0.230 mmol of Mg/kg of the subject's weight and the dose for PEG to be within a range from 0.7 to 1.4 g of PEG/kg of the subject's weight for the second injectable composition; and e) observing at least 29% improvement in lesion volume over a similar dosage of Mg administered alone in saline due to the synergistic effect of co-administering Mg and PEG.
地址 Warsaw IN US